SlideShare a Scribd company logo
1 of 8
IN WOMEN, WEIGHT LOSS
 INCREASES THE RISK FOR
GALLSTONE DISEASE MORE
       THAN OBESITY
        Authors
      Kapantais Efthymios
      Mortoglou Anastasios
      Candiloros Harilaos
      Venaki Evangelia
      Georgiadou Elli
Department of Endocrinology,
      Diabetes & Metabolism


        Athens
        Medical Centre Hospital
        Athens
        GREECE



8th European Congress on Obesity
 Dublin (Ireland) 18-21 June 1997
Introduction
 Obesity is considered to be an important
 risk factor for gallstone disease. Other
 principal risk factors are age, female
 gender and childbearing.

             Purpose
    To investigate if obesity per se
                  OR
Previous weight reduction regimen are
 responsible for for gallstone disease.
Subjects
       1632 Females
  Age >20 yrs
  No use of contaceptives
  No history of aemolytic anaemias
History of cholecystectomy in the past
                  or
         Known cholelithiasis
Methods
Separation into 3 groups
   1. According to previous weight
   reduction
    noTry: never trying loosing weight
    <10kg: loss in the past less than 10 kg
    >10kg: loss in the past more than 10 kg at least once
   2. According to BMI
    BMIGR1: BMI < 30
    BMIGR2: BMI 30 - 40
    BMIGR3: BMI > 40
   3. According to age
    AGEGR1: age 21 - 35
    AGEGR2: age 36 - 50
    AGEGR3: age > 50
Results
               50
           %
               40


               30


               20                                          >10 Kgr


                10                                    <10 Kgr


                    0                              NoTry
                        0
                             1
                                    2
                                            3
                            Children

       Females, age 36 - 50, BMI 30 - 40

 Total Prevalence of known cholelithiasis: 120/1632, 7.35 %
Results                                                                60

                                                                            %
                                                                       40


                                                                       20


                                                                       0

                                                                 0
                  > 10 K gr


                                                        1   Children
                              < 10 K gr


                                                    2
                                          N oT ry




       Females, age >50, BMI >40

 Total Prevalence of known cholelithiasis: 120/1632, 7.35 %
Conclusion
 In women
Weight reducing regimens seem to
increase the risk for gallstone
disease more than obesity per se.
This risk increases relatively to
total weight loss.

More Related Content

Similar to 1997 bile.8th eco

Targeting abdominal obesity in diabetology: What can we do about it?
Targeting abdominal obesity in diabetology: What can we do about it?Targeting abdominal obesity in diabetology: What can we do about it?
Targeting abdominal obesity in diabetology: What can we do about it?My Healthy Waist
 
Case Study: Incidence of Lifestyle Diseases In IT Industry
Case Study: Incidence of Lifestyle Diseases In IT IndustryCase Study: Incidence of Lifestyle Diseases In IT Industry
Case Study: Incidence of Lifestyle Diseases In IT IndustryJust for Hearts
 
Low calory sweetners fens
Low calory sweetners fensLow calory sweetners fens
Low calory sweetners fensdoctorariobo
 
Colorectal Cancer Detection: Fact vs Fiction
Colorectal Cancer Detection: Fact vs FictionColorectal Cancer Detection: Fact vs Fiction
Colorectal Cancer Detection: Fact vs FictionJarrod Lee
 
Bariatric Surgery Hospitals in Hyderabad | Yashoda Hospitals
Bariatric Surgery Hospitals in Hyderabad | Yashoda HospitalsBariatric Surgery Hospitals in Hyderabad | Yashoda Hospitals
Bariatric Surgery Hospitals in Hyderabad | Yashoda HospitalsYashodaHospitals
 
Anthropometry: What Can We Measure & What Does It Mean? - Dr Anne McTiernan
Anthropometry: What Can We Measure & What Does It Mean? - Dr Anne McTiernanAnthropometry: What Can We Measure & What Does It Mean? - Dr Anne McTiernan
Anthropometry: What Can We Measure & What Does It Mean? - Dr Anne McTiernanWorld Cancer Research Fund International
 
Diabetes mellitus; characteristics, epidemiology & risk factors
Diabetes mellitus; characteristics, epidemiology & risk factorsDiabetes mellitus; characteristics, epidemiology & risk factors
Diabetes mellitus; characteristics, epidemiology & risk factorsYousef Biuk
 
Metabolic consequences of obesity
Metabolic consequences of obesityMetabolic consequences of obesity
Metabolic consequences of obesityDr.reena singh
 
Abdominal obesity : the risks factors .Redustim, a medical device solution
Abdominal obesity : the risks factors .Redustim, a medical device solutionAbdominal obesity : the risks factors .Redustim, a medical device solution
Abdominal obesity : the risks factors .Redustim, a medical device solutionCOSMOSOFT SAS
 
Treatment of obesity (and diabetes)
 Treatment of obesity (and diabetes) Treatment of obesity (and diabetes)
Treatment of obesity (and diabetes)ecipenm
 
Antalya-1-Messinis-Obesity-and-Infertility.pptx
Antalya-1-Messinis-Obesity-and-Infertility.pptxAntalya-1-Messinis-Obesity-and-Infertility.pptx
Antalya-1-Messinis-Obesity-and-Infertility.pptxMsccMohamed
 
Does waist circumference predict disease risk beyond metabolic risk factors a...
Does waist circumference predict disease risk beyond metabolic risk factors a...Does waist circumference predict disease risk beyond metabolic risk factors a...
Does waist circumference predict disease risk beyond metabolic risk factors a...PeterJaniszewski
 
Webinar+presentation info mb+ppt-120422
Webinar+presentation info mb+ppt-120422Webinar+presentation info mb+ppt-120422
Webinar+presentation info mb+ppt-120422Ron Haugland
 
Obesity and Cardiovascular Diseases
Obesity and Cardiovascular DiseasesObesity and Cardiovascular Diseases
Obesity and Cardiovascular DiseasesAYESHA KABEER
 

Similar to 1997 bile.8th eco (20)

Harvie opac2013
Harvie opac2013Harvie opac2013
Harvie opac2013
 
Targeting abdominal obesity in diabetology: What can we do about it?
Targeting abdominal obesity in diabetology: What can we do about it?Targeting abdominal obesity in diabetology: What can we do about it?
Targeting abdominal obesity in diabetology: What can we do about it?
 
Slg bmi 30 35
Slg bmi 30 35Slg bmi 30 35
Slg bmi 30 35
 
obesity
obesityobesity
obesity
 
Obesity
ObesityObesity
Obesity
 
Case Study: Incidence of Lifestyle Diseases In IT Industry
Case Study: Incidence of Lifestyle Diseases In IT IndustryCase Study: Incidence of Lifestyle Diseases In IT Industry
Case Study: Incidence of Lifestyle Diseases In IT Industry
 
Low calory sweetners fens
Low calory sweetners fensLow calory sweetners fens
Low calory sweetners fens
 
Colorectal Cancer Detection: Fact vs Fiction
Colorectal Cancer Detection: Fact vs FictionColorectal Cancer Detection: Fact vs Fiction
Colorectal Cancer Detection: Fact vs Fiction
 
Bariatric Surgery Hospitals in Hyderabad | Yashoda Hospitals
Bariatric Surgery Hospitals in Hyderabad | Yashoda HospitalsBariatric Surgery Hospitals in Hyderabad | Yashoda Hospitals
Bariatric Surgery Hospitals in Hyderabad | Yashoda Hospitals
 
Anthropometry: What Can We Measure & What Does It Mean? - Dr Anne McTiernan
Anthropometry: What Can We Measure & What Does It Mean? - Dr Anne McTiernanAnthropometry: What Can We Measure & What Does It Mean? - Dr Anne McTiernan
Anthropometry: What Can We Measure & What Does It Mean? - Dr Anne McTiernan
 
Diabetes mellitus; characteristics, epidemiology & risk factors
Diabetes mellitus; characteristics, epidemiology & risk factorsDiabetes mellitus; characteristics, epidemiology & risk factors
Diabetes mellitus; characteristics, epidemiology & risk factors
 
Metabolic consequences of obesity
Metabolic consequences of obesityMetabolic consequences of obesity
Metabolic consequences of obesity
 
Abdominal obesity : the risks factors .Redustim, a medical device solution
Abdominal obesity : the risks factors .Redustim, a medical device solutionAbdominal obesity : the risks factors .Redustim, a medical device solution
Abdominal obesity : the risks factors .Redustim, a medical device solution
 
Treatment of obesity (and diabetes)
 Treatment of obesity (and diabetes) Treatment of obesity (and diabetes)
Treatment of obesity (and diabetes)
 
Antalya-1-Messinis-Obesity-and-Infertility.pptx
Antalya-1-Messinis-Obesity-and-Infertility.pptxAntalya-1-Messinis-Obesity-and-Infertility.pptx
Antalya-1-Messinis-Obesity-and-Infertility.pptx
 
LC Balance
LC BalanceLC Balance
LC Balance
 
Preventing diabetes
Preventing diabetesPreventing diabetes
Preventing diabetes
 
Does waist circumference predict disease risk beyond metabolic risk factors a...
Does waist circumference predict disease risk beyond metabolic risk factors a...Does waist circumference predict disease risk beyond metabolic risk factors a...
Does waist circumference predict disease risk beyond metabolic risk factors a...
 
Webinar+presentation info mb+ppt-120422
Webinar+presentation info mb+ppt-120422Webinar+presentation info mb+ppt-120422
Webinar+presentation info mb+ppt-120422
 
Obesity and Cardiovascular Diseases
Obesity and Cardiovascular DiseasesObesity and Cardiovascular Diseases
Obesity and Cardiovascular Diseases
 

More from iosis1979

2009 11ο Διαβητολογικό
2009 11ο Διαβητολογικό2009 11ο Διαβητολογικό
2009 11ο Διαβητολογικόiosis1979
 
2008 7ο παχυσαρκίας
2008 7ο παχυσαρκίας2008 7ο παχυσαρκίας
2008 7ο παχυσαρκίαςiosis1979
 
2007 15th eco
2007 15th eco2007 15th eco
2007 15th ecoiosis1979
 
2006 14th ico 2
2006 14th ico 22006 14th ico 2
2006 14th ico 2iosis1979
 
2006 14th ico 1
2006 14th ico 12006 14th ico 1
2006 14th ico 1iosis1979
 
2006 6o παχυσαρκίας
2006 6o παχυσαρκίας2006 6o παχυσαρκίας
2006 6o παχυσαρκίαςiosis1979
 
2005 14th eco3
2005 14th eco32005 14th eco3
2005 14th eco3iosis1979
 
2005 14th eco2
2005 14th eco22005 14th eco2
2005 14th eco2iosis1979
 
2005 14th eco1
2005 14th eco12005 14th eco1
2005 14th eco1iosis1979
 
2004 13th eco
2004 13th eco2004 13th eco
2004 13th ecoiosis1979
 
2003 18th idf
2003 18th idf2003 18th idf
2003 18th idfiosis1979
 
1999 26ο ενδοκρινολογίας2
1999 26ο ενδοκρινολογίας21999 26ο ενδοκρινολογίας2
1999 26ο ενδοκρινολογίας2iosis1979
 
1999 26o eνδοκρινολογίας1
1999 26o eνδοκρινολογίας11999 26o eνδοκρινολογίας1
1999 26o eνδοκρινολογίας1iosis1979
 
1999 3ο παχυσαρκίας3
1999 3ο παχυσαρκίας31999 3ο παχυσαρκίας3
1999 3ο παχυσαρκίας3iosis1979
 
1999 3ο παχυσαρκίας2
1999 3ο παχυσαρκίας21999 3ο παχυσαρκίας2
1999 3ο παχυσαρκίας2iosis1979
 
1999 3ο παχυσαρκίας1
1999 3ο παχυσαρκίας11999 3ο παχυσαρκίας1
1999 3ο παχυσαρκίας1iosis1979
 
1998 ιco 8th
1998 ιco 8th1998 ιco 8th
1998 ιco 8thiosis1979
 
1998 8th ico
1998 8th ico1998 8th ico
1998 8th icoiosis1979
 
1997 alcohol 8th eco
1997 alcohol 8th eco1997 alcohol 8th eco
1997 alcohol 8th ecoiosis1979
 

More from iosis1979 (20)

Easd 2007
Easd 2007Easd 2007
Easd 2007
 
2009 11ο Διαβητολογικό
2009 11ο Διαβητολογικό2009 11ο Διαβητολογικό
2009 11ο Διαβητολογικό
 
2008 7ο παχυσαρκίας
2008 7ο παχυσαρκίας2008 7ο παχυσαρκίας
2008 7ο παχυσαρκίας
 
2007 15th eco
2007 15th eco2007 15th eco
2007 15th eco
 
2006 14th ico 2
2006 14th ico 22006 14th ico 2
2006 14th ico 2
 
2006 14th ico 1
2006 14th ico 12006 14th ico 1
2006 14th ico 1
 
2006 6o παχυσαρκίας
2006 6o παχυσαρκίας2006 6o παχυσαρκίας
2006 6o παχυσαρκίας
 
2005 14th eco3
2005 14th eco32005 14th eco3
2005 14th eco3
 
2005 14th eco2
2005 14th eco22005 14th eco2
2005 14th eco2
 
2005 14th eco1
2005 14th eco12005 14th eco1
2005 14th eco1
 
2004 13th eco
2004 13th eco2004 13th eco
2004 13th eco
 
2003 18th idf
2003 18th idf2003 18th idf
2003 18th idf
 
1999 26ο ενδοκρινολογίας2
1999 26ο ενδοκρινολογίας21999 26ο ενδοκρινολογίας2
1999 26ο ενδοκρινολογίας2
 
1999 26o eνδοκρινολογίας1
1999 26o eνδοκρινολογίας11999 26o eνδοκρινολογίας1
1999 26o eνδοκρινολογίας1
 
1999 3ο παχυσαρκίας3
1999 3ο παχυσαρκίας31999 3ο παχυσαρκίας3
1999 3ο παχυσαρκίας3
 
1999 3ο παχυσαρκίας2
1999 3ο παχυσαρκίας21999 3ο παχυσαρκίας2
1999 3ο παχυσαρκίας2
 
1999 3ο παχυσαρκίας1
1999 3ο παχυσαρκίας11999 3ο παχυσαρκίας1
1999 3ο παχυσαρκίας1
 
1998 ιco 8th
1998 ιco 8th1998 ιco 8th
1998 ιco 8th
 
1998 8th ico
1998 8th ico1998 8th ico
1998 8th ico
 
1997 alcohol 8th eco
1997 alcohol 8th eco1997 alcohol 8th eco
1997 alcohol 8th eco
 

1997 bile.8th eco

  • 1. IN WOMEN, WEIGHT LOSS INCREASES THE RISK FOR GALLSTONE DISEASE MORE THAN OBESITY Authors Kapantais Efthymios Mortoglou Anastasios Candiloros Harilaos Venaki Evangelia Georgiadou Elli
  • 2. Department of Endocrinology, Diabetes & Metabolism Athens Medical Centre Hospital Athens GREECE 8th European Congress on Obesity Dublin (Ireland) 18-21 June 1997
  • 3. Introduction  Obesity is considered to be an important risk factor for gallstone disease. Other principal risk factors are age, female gender and childbearing. Purpose To investigate if obesity per se OR Previous weight reduction regimen are responsible for for gallstone disease.
  • 4. Subjects 1632 Females  Age >20 yrs  No use of contaceptives  No history of aemolytic anaemias History of cholecystectomy in the past or Known cholelithiasis
  • 5. Methods Separation into 3 groups 1. According to previous weight reduction  noTry: never trying loosing weight  <10kg: loss in the past less than 10 kg  >10kg: loss in the past more than 10 kg at least once 2. According to BMI  BMIGR1: BMI < 30  BMIGR2: BMI 30 - 40  BMIGR3: BMI > 40 3. According to age  AGEGR1: age 21 - 35  AGEGR2: age 36 - 50  AGEGR3: age > 50
  • 6. Results 50 % 40 30 20 >10 Kgr 10 <10 Kgr 0 NoTry 0 1 2 3 Children Females, age 36 - 50, BMI 30 - 40 Total Prevalence of known cholelithiasis: 120/1632, 7.35 %
  • 7. Results 60 % 40 20 0 0 > 10 K gr 1 Children < 10 K gr 2 N oT ry Females, age >50, BMI >40 Total Prevalence of known cholelithiasis: 120/1632, 7.35 %
  • 8. Conclusion  In women Weight reducing regimens seem to increase the risk for gallstone disease more than obesity per se. This risk increases relatively to total weight loss.